MediWound Overview
- Year Founded
-
2000
- Status
-
Public
- Employees
-
121
- Stock Symbol
-
MDWD
- Investments
-
1
- Share Price
-
$13.55
- (As of Thursday Closing)
MediWound General Information
Description
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.
Contact Information
Website
www.mediwound.comCorporate Office
- 42 Hayarkon Street
- Yavne 8122745
- Israel
Corporate Office
- 42 Hayarkon Street
- Yavne 8122745
- Israel
MediWound Timeline
MediWound Stock Performance
As of 19-Nov-2026, MediWound’s stock price is $13.55. Its current market cap is $195M with 14.4M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $13.55 | $13.61 | $11.80 - $19.70 | $195M | 14.4M | 124K | -$1.83 |
MediWound Financials Summary
As of 30-Sep-2026, MediWound has a trailing 12-month revenue of $10M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 151,039 | 185,865 | 152,961 | 54,172 |
| Revenue | 10,007 | 16,959 | 20,222 | 18,686 |
| EBITDA | (31,852) | (23,329) | (29,976) | (7,142) |
| Net Income | (23,514) | (23,879) | (30,224) | (6,716) |
| Total Assets | 65,495 | 86,255 | 73,496 | 66,459 |
| Total Debt | 8,305 | 8,152 | 6,513 | 6,350 |
MediWound Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
MediWound Comparisons
Industry
Financing
Details
MediWound Competitors (2)
One of MediWound’s 2 competitors is NOVADIP, a Venture Capital-Backed company based in Mont-Saint-Guibert, Belgium.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| NOVADIP | Venture Capital-Backed | Mont-Saint-Guibert, Belgium | ||||
| SolasCure | Venture Capital-Backed | Cambridge, United Kingdom |
MediWound Patents
MediWound Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2022230097-A1 | Proteolytic enzyme mixture for treating psoriasis | Inactive | 01-Mar-2021 | ||
| CA-3210372-A1 | Proteolytic enzyme mixture for treating psoriasis | Pending | 01-Mar-2021 | ||
| EP-4301401-A1 | Proteolytic enzyme mixture for treating psoriasis | Inactive | 01-Mar-2021 | ||
| EP-4301401-A4 | Proteolytic enzyme mixture for treating psoriasis | Inactive | 01-Mar-2021 | ||
| US-20240148842-A1 | Proteolytic enzyme mixture for treating psoriasis | Inactive | 01-Mar-2021 | A61K38/4873 |
MediWound Signals
MediWound Acquisitions (1)
MediWound’s most recent deal was a Merger/Acquisition with Polyheal for . The deal was made on 09-Nov-2010.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Polyheal | 09-Nov-2010 | Merger/Acquisition | Surgical Devices |
MediWound ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
MediWound FAQs
-
When was MediWound founded?
MediWound was founded in 2000.
-
Where is MediWound headquartered?
MediWound is headquartered in Yavne, Israel.
-
What is the size of MediWound?
MediWound has 121 total employees.
-
What industry is MediWound in?
MediWound’s primary industry is Pharmaceuticals.
-
Is MediWound a private or public company?
MediWound is a Public company.
-
What is MediWound’s stock symbol?
The ticker symbol for MediWound is MDWD.
-
What is the current stock price of MediWound?
As of 19-Nov-2026 the stock price of MediWound is $13.55.
-
What is the current market cap of MediWound?
The current market capitalization of MediWound is $195M.
-
What is MediWound’s current revenue?
The trailing twelve month revenue for MediWound is $10M.
-
Who are MediWound’s competitors?
-
What is MediWound’s annual earnings per share (EPS)?
MediWound’s EPS for 12 months was -$1.83.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process